1. Design, Synthesis and Biological Evaluation of N -phenylindole Derivatives as Pks13 Inhibitors against Mycobacterium tuberculosis.
- Author
-
Cai, Yanpeng, Zhang, Wei, Lun, Shichun, Zhu, Tongtong, Xu, Weijun, Yang, Fan, Tang, Jie, Bishai, William R., and Yu, Lifang
- Subjects
- *
BIOSYNTHESIS , *MYCOBACTERIUM tuberculosis , *POLYKETIDES , *STRUCTURE-activity relationships , *CRYSTAL structure , *HYDROGEN bonding - Abstract
Polyketide synthase 13 (Pks13), an essential enzyme for the survival of Mycobacterium tuberculosis (Mtb), is an attractive target for new anti-TB agents. In our previous work, we have identified 2-phenylindole derivatives against Mtb. The crystallography studies demonstrated that the two-position phenol was solvent-exposed in the Pks13-TE crystal structure and a crucial hydrogen bond was lost while introducing bulkier hydrophobic groups at indole N moieties. Thirty-six N-phenylindole derivatives were synthesized and evaluated for antitubercular activity using a structure-guided approach. The structure–activity relationship (SAR) studies resulted in the discovery of the potent Compounds 45 and 58 against Mtb H37Rv, with an MIC value of 0.0625 μg/mL and 0.125 μg/mL, respectively. The thermal stability analysis showed that they bind with high affinity to the Pks13-TE domain. Preliminary ADME evaluation showed that Compound 58 displayed modest human microsomal stability. This report further validates that targeting Pks13 is a valid strategy for the inhibition of Mtb and provides a novel scaffold for developing leading anti-TB compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF